Aster DM Heathcare plans India expansion
Investment of Rs 235 crores to add 411 beds in the next 18 months
Investment of Rs 235 crores to add 411 beds in the next 18 months
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
EPS for the period at Rs. (7.57)
The company reports revenue growth of 26% and PAT growth of 21% YoY
The antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses and on contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA)
The group has a total of 320 ANDA approvals
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
The MoU was signed on World Organ Donation Day which falls on August 13
This is the first of its kind vaccine for Covid 19 to get the go-ahead
Subscribe To Our Newsletter & Stay Updated